Overview
Radiation therapy (also called radiotherapy) is commonly used to treat solitary plasmacytoma – an early stage of multiple myeloma involving a single lesion in the bone or soft tissues. Plasmacytoma that occurs… read more
Overview
Abecma is a therapy approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory multiple myeloma after four or more prior therapies, including an immunomodulatory agent,… read more
Overview
Carvykti is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory multiple myeloma in adults who have already tried at least four lines of therapy.… read more